Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ILOPERIDONE vs IMDEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ILOPERIDONE vs IMDEVIMAB: Safety Overview

Metric ILOPERIDONE IMDEVIMAB
Total FAERS Reports 508 432
Deaths Reported 13 24
Death Rate 2.6% 5.6%
Hospitalizations 50 202
Average Patient Age 36.4 yrs 56.2 yrs
% Female Patients 49.8% 52.7%
FDA Approval Date Jul 22, 2019 N/A
Manufacturer Mylan Pharmaceuticals Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A